Key Highlights

  • Third-quarter 2026 Revenue was USD 1.5 million, against USD 0.5 million a year earlier.
  • A Goodwill Impairment expense of USD 323.5 million was recorded.
  • Net loss attributable to stockholders was USD 202.4 million, or USD 2.39 per share.
  • Cash and cash equivalents were USD 22.0 million as of September 30, 2026.

Innventure (NASDAQ:INV) reported revenue of USD 1.5 million for the third quarter ended September 30, 2026, against an estimate of USD 892.67 thousand and USD 0.5 million in the third quarter of 2025. Net loss was USD 2.39 per share, against an estimate of a loss of USD 0.26 and USD 0.51 a year earlier. The company builds and operates technology companies that it calls Innventure Companies.

Quarterly Financial Results

Revenue increased USD 0.9 million, or 177.3%, which the company attributed to an increase in product sales and service revenue in the Technology segment. Cost of sales was USD 5.2 million, against USD 4.1 million, which it linked to higher supplies and materials, amortization of intangible Assets and employee costs.

General and administrative expense was USD 12.8 million, against USD 16.9 million, a decrease of 24.1% that the company attributed to lower stock-based compensation and lower professional and legal fees. Sales and Marketing expense was USD 1.9 million, against USD 2.5 million. Interest expense, net, was USD 0.9 million, against USD 3.4 million.

The company recorded goodwill impairment expense of USD 323.5 million. Total net loss was USD 333.8 million, against USD 34.7 million, of which USD 131.5 million was attributable to non-controlling interest. Net loss attributable to Innventure stockholders was USD 202.4 million, against USD 28.3 million, and weighted-average shares were 84.7 million.

Nine-Month Results

For the nine months ended September 30, 2026, revenue was USD 3.9 million, against USD 1.2 million, and cost of sales was USD 15.5 million, against USD 7.2 million. General and administrative expense was USD 40.1 million, against USD 55.2 million, a decrease of 27.3%. Sales and marketing expense was USD 7.9 million, against USD 6.8 million, and Research and Development expense was USD 27.1 million, against USD 18.5 million.

Net loss attributable to stockholders was USD 249.7 million, or USD 3.05 per share, against USD 255.6 million, or USD 4.96 per share. Net cash used in investing activities was USD 4.3 million, and net cash provided by financing activities was USD 40.4 million, against USD 63.3 million.

Liquidity and Going-Concern Disclosure

Cash and cash equivalents were USD 22.0 million as of September 30, 2026, against USD 60.4 million at December 31, 2025, with restricted cash of USD 5.0 million in both periods. Working Capital was USD 5.8 million, against USD 6.9 million. Accounts receivable, net, were USD 2.1 million, against USD 1.1 million, and inventories were USD 2.7 million, against USD 1.6 million. Total current assets were USD 53.2 million, against USD 83.2 million, and investments were USD 25.5 million. The filing states that management determined its conditions raise substantial doubt about the company's ability to continue as a Going Concern within one year after the date the financial statements were issued.

The filing adds that if the company cannot obtain adequate capital from Equity or debt financing, or generate sufficient revenues from the Innventure Companies, it may have to implement additional cost reductions.